Y.S.P. Southeast Asia Holding BhdXKLS:7178 +2.39%76 Operating Margin % is 14.09% as of Mar. 2026, which is 23% above its 10-year median of 11.47. GuruFocus rates XKLS:7178 with a GF Score™ of 76/100 and a GF Value™ of RM2.40 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, Y.S.P. Southeast Asia Holding Bhd ranks better than 54.97% on this metric.
Y.S.P. Southeast Asia Holding Bhd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Y.S.P. Southeast Asia Holding Bhd's Operating Margin % or its related term are showing as below:
XKLS:7178'
s Operating Margin % Range Over the Past 10 Years
Min: 8.39 Med: 11.47 Max: 15.52
Current: 9.95
XKLS:7178's Operating Margin % is ranked better than 54.97% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs XKLS:7178: 9.95
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Y.S.P. Southeast Asia Holding Bhd Operating Margin % Related Terms
Y.S.P. Southeast Asia Holding Bhd Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd Operating Margin % Chart
XKLS:7178 vs ZTS, UTHR, VTRS: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Operating Margin % falls into.
Y.S.P. Southeast Asia Holding Bhd Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a Operating Margin % of 14.09% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is 23% above median its historical median of 11.47. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's Operating Margin % has ranged from 8.39 to 15.52. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #430 out of 955 companies in the Drug Manufacturers industry, placing it in the top 45%.
Is Y.S.P. Southeast Asia Holding Bhd's Operating Margin % too high?
Y.S.P. Southeast Asia Holding Bhd's current Operating Margin % of 14.09% is 23% above median its 10-year median of 11.47. Over the past 10 years, this metric has ranged from a low of 8.39 to a high of 15.52. The Drug Manufacturers industry median Operating Margin % is 7.45. Y.S.P. Southeast Asia Holding Bhd's value of 14.09% is 89.1% above this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #430 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #430 out of 955 companies for Operating Margin %. This puts Y.S.P. Southeast Asia Holding Bhd in the upper half of its industry. The industry median Operating Margin % is 7.45. Y.S.P. Southeast Asia Holding Bhd's value of 14.09% is 89.1% above this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own Operating Margin % has ranged from 8.39 to 15.52 over the past decade. While the company's 10-year median is 11.47 vs. the industry median of 7.45, Y.S.P. Southeast Asia Holding Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current Operating Margin % of 14.09% is 89.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current Operating Margin % is 14.09%, which is 23% above median its own 10-year median of 11.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.14 — trading 10.8% below its estimated fair value. The current Operating Margin % is 14.09%, which is 23% above median its 10-year median of 11.47 and 89.1% above the Drug Manufacturers industry median of 7.45. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current Operating Margin % is 14.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.14 is trading 10.8% below its estimated GF Value™ of RM2.40.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
Operating Margin %: 14.09% (23% above median its 10-year median of 11.47)
GF Value™: RM2.40 vs. price of RM2.14 (10.8% below fair value)
Industry Position: 89.1% above the Drug Manufacturers median (#430 of 955)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
76GF Score
Get the complete analysis for XKLS:7178
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
